Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Feb 23, 2016 8:30 am EST

OPKO Health Announces Dosing of First Patient in Phase 2a Clinical Study of a Long-Acting Factor VIIa for the Treatment of Hemophilia

Feb 23, 2016 8:00 am EST

OPKO to Announce 2015 Fourth Quarter and Full Year Financial Results on February 29, 2016

Feb 18, 2016 10:49 am EST

OPKO Health to Present at the RBC Capital Markets Global Healthcare Conference

Feb 9, 2016 8:30 am EST

Study Demonstrates OPKO’s 4Kscore Test Reduces Unnecessary Prostate Biopsies While Improving Risk Prediction for Aggressive Prostate Cancer

Jan 22, 2016 8:30 am EST

OPKO’s GeneDx to Present at Personalized Medicine World Conference

Jan 6, 2016 4:05 pm EST

OPKO Health to Present at the J.P. Morgan 34th Annual Healthcare Conference

Jan 5, 2016 4:48 pm EST

Conversion Right Extended on OPKO 3.0% Convertible Senior Notes

Dec 21, 2015 8:30 am EST

OPKO’s GeneDx Study of More Than 10,000 Individuals Tested with Multigene NGS Hereditary Cancer Panel Reveals New Risks

Dec 9, 2015 8:30 am EST

OPKO’s GeneDx Study Demonstrates Whole Exome Sequencing Usefulness In Diagnosing Rare Disorders

Dec 2, 2015 10:27 am EST

OPKO Health to Present at the Oppenheimer 26th Annual Healthcare Conference